Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions

Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions

The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bebernitz, Gregory R, Gupta, Ramesh C, Jagtap, Vikrant V, Mandhare, Appaji B, Tuli, Davinder
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Bebernitz, Gregory R
Gupta, Ramesh C
Jagtap, Vikrant V
Mandhare, Appaji B
Tuli, Davinder
description The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07781451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07781451</sourcerecordid><originalsourceid>FETCH-uspatents_grants_077814513</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRdNYiHqHOYCCQSXpRfEA6WXYnWQHN7NhdxLQyqO7AQtLq_fhPf6yeDeO8RV8GJ6RLQuBpcgTKk-UtjA4jD0aGhXYoAcTxLJykDRPRRaWDtRRDygWelIXbILQgkbKJ1l2fjThwYKJsreMSvbnZ10sWvSJNl-uCrhemvNtN6Yhp6Lp3kWcsa-qujyeysMfyQfGA0uy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions</title><source>USPTO Issued Patents</source><creator>Bebernitz, Gregory R ; Gupta, Ramesh C ; Jagtap, Vikrant V ; Mandhare, Appaji B ; Tuli, Davinder</creator><creatorcontrib>Bebernitz, Gregory R ; Gupta, Ramesh C ; Jagtap, Vikrant V ; Mandhare, Appaji B ; Tuli, Davinder ; Novartis AG</creatorcontrib><description>The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7781451$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7781451$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bebernitz, Gregory R</creatorcontrib><creatorcontrib>Gupta, Ramesh C</creatorcontrib><creatorcontrib>Jagtap, Vikrant V</creatorcontrib><creatorcontrib>Mandhare, Appaji B</creatorcontrib><creatorcontrib>Tuli, Davinder</creatorcontrib><creatorcontrib>Novartis AG</creatorcontrib><title>Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions</title><description>The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjDEKwkAQRdNYiHqHOYCCQSXpRfEA6WXYnWQHN7NhdxLQyqO7AQtLq_fhPf6yeDeO8RV8GJ6RLQuBpcgTKk-UtjA4jD0aGhXYoAcTxLJykDRPRRaWDtRRDygWelIXbILQgkbKJ1l2fjThwYKJsreMSvbnZ10sWvSJNl-uCrhemvNtN6Yhp6Lp3kWcsa-qujyeysMfyQfGA0uy</recordid><startdate>20100824</startdate><enddate>20100824</enddate><creator>Bebernitz, Gregory R</creator><creator>Gupta, Ramesh C</creator><creator>Jagtap, Vikrant V</creator><creator>Mandhare, Appaji B</creator><creator>Tuli, Davinder</creator><scope>EFH</scope></search><sort><creationdate>20100824</creationdate><title>Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions</title><author>Bebernitz, Gregory R ; Gupta, Ramesh C ; Jagtap, Vikrant V ; Mandhare, Appaji B ; Tuli, Davinder</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_077814513</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bebernitz, Gregory R</creatorcontrib><creatorcontrib>Gupta, Ramesh C</creatorcontrib><creatorcontrib>Jagtap, Vikrant V</creatorcontrib><creatorcontrib>Mandhare, Appaji B</creatorcontrib><creatorcontrib>Tuli, Davinder</creatorcontrib><creatorcontrib>Novartis AG</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bebernitz, Gregory R</au><au>Gupta, Ramesh C</au><au>Jagtap, Vikrant V</au><au>Mandhare, Appaji B</au><au>Tuli, Davinder</au><aucorp>Novartis AG</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions</title><date>2010-08-24</date><risdate>2010</risdate><abstract>The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07781451
source USPTO Issued Patents
title Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bebernitz,%20Gregory%20R&rft.aucorp=Novartis%20AG&rft.date=2010-08-24&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07781451%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true